Rocket Lab's stock closed at $59.18 on October 14 after dropping nearly 8% on the company's announcement that its first Neutron rocket launch would slip into 2027 due to a manufacturing defect in the payload fairing dome. This recent catalyst has weighed on near-term price expectations despite robust underlying momentum, including Q2 revenue of $234 million (up 62% year-over-year), a record $2.36 billion backlog, and the largest-ever Electron commercial contract for 20 launches. Progress on the pending Iridium acquisition, expected to close in mid-2027 and improve profitability, plus upcoming Q3 results on November 9, remain key factors influencing trader positioning around October price thresholds. Analyst consensus targets average near $103 with a Buy rating.